TÜRKÇE
ENGLISH
Information
| Code | ECS526 |
| Name | Pathogenicity and Antipatogenic molecules |
| Term | 2022-2023 Academic Year |
| Semester | 10. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 3 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Lisans Dersi |
| Type | Normal |
| Label | E Elective |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | Dr. Öğr. Üyesi ABDURRAHMAN AYGÜL |
| Course Instructor |
Doç. Dr. UMAY MERVE GÜVEN
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
It is aimed to provide information about the pathogenesis of infectious diseases, the role of microbial virulence factors in the pathogenesis processes and the molecules that inhibit virulence factors.
Course Content
Common pathogens in infectious diseases, pathogenicity, pathogenesis, virulence, antipathogenic molecules
Course Precondition
None.
Resources
None.
Notes
None.
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Explain the concept of pathogenesis |
| LO02 | Explain the concept of virulence |
| LO03 | Counts virulence factors for attachment in the infection process |
| LO04 | Counts virulence factors for invasion in the infection process |
| LO05 | Explain the concept of biofilm |
| LO06 | Explain the concept of quorum sensing |
| LO07 | Gives examples for attachment inhibitors |
| LO08 | Gives examples for bacterial toxin inhibitors |
| LO09 | Gives examples for bacterial enzyme inhibitors |
| LO10 | Gives examples for biofilm inhibitors |
| LO11 | Gives examples for quorum sensing inhibitors |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Bilgi - Kuramsal, Olgusal | Have sufficient knowledge in pharmaceutical field and develop the knowledge. | 3 |
| PLO02 | Bilgi - Kuramsal, Olgusal | Comprehends professional knowledge with ethical responsibility through current laws and legislation. | |
| PLO03 | Beceriler - Bilişsel, Uygulamalı | Provides consultancy service to patients, community and health care personnel and evaluates advanced knowledge and skills with a critical approach. | 2 |
| PLO04 | Beceriler - Bilişsel, Uygulamalı | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | |
| PLO05 | Beceriler - Bilişsel, Uygulamalı | Have the knowledge and skills to help provide patient-oriented pharmacy applications and individualized pharmaceutical care by learning the basics of Clinical Pharmacy, | |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | |
| PLO07 | Yetkinlikler - Öğrenme Yetkinliği | Integrates and develops professional knowledge via different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 5 |
| PLO08 | Yetkinlikler - Öğrenme Yetkinliği | Use effectively the concepts and applications of basic sciences and basic medical sciences in the field of medicine and pharmacy and update the information. | 4 |
| PLO09 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Communicates effectively in writing and speaking. | |
| PLO10 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Practices the profession in accordance with Atatürk's principles and reforms, equipped with universal knowledge, uses Turkish correctly and knows at least one foreign language. | |
| PLO11 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Be an example to society withexternal appearance, demeanor, attitude and behavior for the other professionals and society and with professional identity | |
| PLO12 | Yetkinlikler - Alana Özgü Yetkinlik | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | 4 |
| PLO13 | Yetkinlikler - Alana Özgü Yetkinlik | Interprets information about current health and treatment problems and attends meeting on related matters . Plays an active role in community health. | 3 |
| PLO14 | Yetkinlikler - Alana Özgü Yetkinlik | Acquires basic information about diseases, makes decisions about the drugs used in treatment in accordance with rational drug use. |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Pathogenesis, pathogenicity and virulence factors in infectious diseases | Reading lecture notes | |
| 2 | Virulence factors associated with attachment | Reading lecture notes | |
| 3 | Exoenzymes and toxins | Reading lecture notes | |
| 4 | Virulence factors developed against host immunity | Reading lecture notes | |
| 5 | Biofilms | Reading lecture notes | |
| 6 | Quorum-sensing | Reading lecture notes | |
| 7 | Summary of previous weeks | Reading lecture notes | |
| 8 | Mid-Term Exam | Subject repetition | |
| 9 | Introduction to antipathogenic molecules | Lecture notes | |
| 10 | Antipathogenic molecules that inhibit microbial adhesion | Lecture notes | |
| 11 | Antipathogenic molecules that inhibit microbial exoenzymes | Lecture notes | |
| 12 | Antipathogenic molecules that inhibit microbial toxins | Lecture notes | |
| 13 | Biofilm inhibitors | Lecture notes | |
| 14 | Quorum-sensing inhibitors | Lecture notes | |
| 15 | Summary of previous weeks 2 | Lecture notes | |
| 16 | Term Exams | Subject repetition | |
| 17 | Term Exams | Subject repetition |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 6 | 6 |
| Final Exam | 1 | 16 | 16 |
| Total Workload (Hour) | 78 | ||
| Total Workload / 25 (h) | 3,12 | ||
| ECTS | 3 ECTS | ||